19.04.2013 - French diabetes specialist Poxel SA (Lyon) has beefed up its business strategy expertise by appointing Khoso Baluch to its Board of Directors.
Baluch is currently Senior VP & President European Region at Belgian UCB SA. Prior to his career there, he worked with Eli Lilly for 24 years, holding international positions in General Management, Business Development, Market Access and Product Leadership. He served as a Board Member of the Juvenile Diabetes Research Foundation, Indiana Chapter, and was Chair of the nomination committee. He also served at the American Diabetes Association National Industry Advisory Board and is also a member of the World Federation of Advertisers (WFA) Executive Committee. Poxel was spun-out from Merck Serono in 2009.